Recent Advances in Parkinson's Disease
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 4912
Special Issue Editor
Special Issue Information
Dear Colleagues,
Parkinson’s disease is the second most common neurodegenerative disease in the world and affects millions of people globally. Much is left to discover about this disease. There is no resolutive treatment; the cause is unknown; diagnostic tools are scanty; and, so far, it remains essentially a clinical diagnosis.
However, in the recent decades several treatments have been available that alleviate signs and symptoms. Pathogenesis as well as some genetic aspects have been partially clarified and linked to clinical pictures. Magnetic Resonance is being used to study brain modification related to the disease. Other diagnostic tools are being developed, and we are about to reach the goal of personalized medicine applied to Parkinson’s disease.
We need to assess our current position in order to move forward.
Dr. Mario Rango
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genetics
- treatment
- magnetic resonance
- pathogenesis
- mitochondria
- metabolomics
- proteomics
- neurosurgery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.